Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SOFRACORT STERILE EAR/EYE OINTMENT 5 MG

FRAMYCETIN SULFATE : 5 MG DEXAMETHASONE : 0.5 MG GRAMICIDIN : 0.05 MG · DIN 01987720 · HOECHST ROUSSEL CANADA INC.

Health Canada status: CANCELLED POST MARKET

What is SOFRACORT STERILE EAR/EYE OINTMENT?

SOFRACORT STERILE EAR/EYE OINTMENT 5 MG contains FRAMYCETIN SULFATE : 5 MG DEXAMETHASONE : 0.5 MG GRAMICIDIN : 0.05 MG. It is listed in the Health Canada Drug Product Database under DIN 01987720, held by HOECHST ROUSSEL CANADA INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Jul-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What else is SOFRACORT STERILE EAR/EYE OINTMENT called?

The same molecule, DEXAMETHASONE AND ANTIINFECTIVES, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
OzurdexLatinAustralia, Bahrain, South Africa
DECADRONLatinBahrain, Morocco
DEXAMETHASONE MYLANLatinMorocco
DexmethsoneLatinAustralia
APO-DEXAMETHASONELatinBahrain
DEXAMETHASONE KRKALatinCzechia
DEXAMETHASONE NORIDEMLatinCzechia
DEXAMETHASONE ZENTIVALatinCzechia
DUCRESSALatinBahrain, Saudi Arabia
FORTECORTINLatinCzechia
MaxidexLatinBahrain, South Africa
MaxitrolLatinSaudi Arabia, South Africa
ORADEXONLatinMorocco
ORADEXON ELIXIRLatinMorocco
TOBRADEXLatinBahrain

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN01987720
Brand nameSOFRACORT STERILE EAR/EYE OINTMENT
Generic / active ingredientFRAMYCETIN SULFATE : 5 MG DEXAMETHASONE : 0.5 MG GRAMICIDIN : 0.05 MG
ManufacturerHOECHST ROUSSEL CANADA INC.
Strength5 MG
Dosage formOINTMENT
Route of administrationTOPICAL
SchedulePrescription
ATC codeS03CA01 DEXAMETHASONE AND ANTIINFECTIVES
AHFS class52:04.04 ; 52:08.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date20-Jul-2001
Original market date1966-12-31 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)01987720
DIN (unpadded, as printed on some documents)1987720
Brand nameSOFRACORT STERILE EAR/EYE OINTMENT
Active ingredient / INNFRAMYCETIN SULFATE : 5 MG DEXAMETHASONE : 0.5 MG GRAMICIDIN : 0.05 MG
ATC codeS03CA01
ATC anatomical main groupS — Sensory organs
ATC therapeutic subgroupS03
AHFS class52:04.04 ; 52:08.00
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderHOECHST ROUSSEL CANADA INC.

Which pack is which?

Strength on the label5 MG
Dosage formOINTMENT
RouteTOPICAL

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

Is DEXAMETHASONE AND ANTIINFECTIVES in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Active — reported by STERIMAX INC (Tier 3 shortage DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP" aria-label="Actual Tier 3 shortage DEXAMETHASONE SODIUM P), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for SOFRACORT STERILE EAR/EYE OINTMENT

What can be used instead?

Other Canadian products sharing ATC code S03CA01 DEXAMETHASONE AND ANTIINFECTIVES. 1 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
SOFRACORT5 MGDROPSCHEPLAPHARM ARZNEIMITTEL GMBHMARKETEDDIN 02224623
NEODECADRON EYE EAR SOLN 0.1%1 MGLIQUIDMERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.CANCELLED POST MARKETDIN 00140732
SANDOZ OPTICORT0.5 MGSOLUTIONSANDOZ CANADA INCORPORATEDCANCELLED POST MARKETDIN 02247920
SOFRACORT EAR/EYE OINTMENT5 MGOINTMENTROUSSEL CANADA INC.CANCELLED POST MARKETDIN 00173606
SOFRACORT EYE/EAR DROPS0.5 MGDROPSROUSSEL CANADA INC.CANCELLED POST MARKETDIN 00228052
SOFRACORT STERILE EAR/EYE DROPS0.5 MGDROPSHOECHST ROUSSEL CANADA INC.CANCELLED POST MARKETDIN 01987712
SOFRACORT STERILE EAR/EYE OINTMENT5 MGOINTMENTAVENTIS PHARMA INCCANCELLED POST MARKETDIN 02224631

Who else supplies DEXAMETHASONE AND ANTIINFECTIVES worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DEXAMETHASONE AND ANTIINFECTIVES appears in 2222 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does DEXAMETHASONE AND ANTIINFECTIVES cost around the world?

DEXAMETHASONE AND ANTIINFECTIVES is listed on 14 national price registers Nexara tracks, across 276 pack listings published on 12 different price bases. What each country publishes is set out below.

MarketWhat that country publishesBrands listedPack listingsAs of
United Statesacquisition1510103 Sep 2026
Greeceproducer price (ex-factory)616103 Sep 2026
Saudi Arabiapublic181801 Sep 2026
United Kingdomhospital161631 Aug 2026
Bahrainretail (max)111401 Sep 2026
MoroccoPPV (public price)61205 Sep 2026
South Africasingle exit price121201 Sep 2026
Czechiamax producer price (ex-factory)61003 Sep 2026
Luxembourgreimbursement9905 Sep 2026
United Arab Emiratespublic8831 Aug 2026
Australiaex-manufacturer2808 Sep 2026
AustriaKVP (Kassenverkaufspreis)3503 Sep 2026
Hungaryproducer price (ex-factory)1103 Sep 2026
Lebanonpublic price (USD, Decision 119/1)1102 Sep 2026

Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.

Ask Nexara for a landed Canadian price

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 01987720. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.